Screening of investigational agents through the ninds preclinical screening platform for pain (pspp)
Ended Awarded Last action
- Contract number
- 75N95019F00088
- Awardee
-
Psychogenics Inc. UEI YXMNA8N7LFG4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $45,906,482
Award facts
- Opportunity
-
- Screening of Investigational Agents through the NINDS Preclinical Screening Platform for Pain (PSPP) Pre-Solicitation · NIHNINDS75N95019R00027 · Posted Jan 30, 2019
- Screening of Investigational Agents through the "NINDS Preclinical Screening Platform for Pain" (PSPP) Award Notice · Posted Mar 27, 2019
- Contract value 100% obligated
- $45,906,481.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Paramus, NJ 07652, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $9,216,959 | |
| Funding Only Action | -$750,010 | |
| Exercise an Option | $12,383,618 | |
| Exercise an Option | $10,683,882 | |
| Exercise an Option | $207,143 | |
| Exercise an Option | $8,339,730 | |
| Other Administrative Action | $0 | |
| Original award | $5,825,160 |
About this award
Psychogenics Inc., doing business as Psychogenics Inc., has been awarded a $45.9 million delivery order contract by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to provide screening of investigational agents through the Preclinical Screening Platform for Pain. The cost plus fixed fee contract will be performed over a five year period in Paramus, New Jersey. Under the contract, Psychogenics will screen investigational pain treatment agents through the NINDS Preclinical Screening Platform for Pain program, which evaluates potential therapies in preclinical models. No subcontractors or set aside designations were identified. The contract was awarded utilizing the NINDS' research support contracts and will further the Institute's mission of transforming the understanding and treatment of neurological diseases.
Quick answers
Who was awarded contract 75N95019F00088?
75N95019F00088 was awarded to Psychogenics Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 26, 2019.
How much is contract 75N95019F00088 worth?
The government has obligated $45,906,482 on 75N95019F00088.
Which agency awarded contract 75N95019F00088?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019F00088, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95019F00088 an order under another contract?
Yes. 75N95019F00088 is a delivery order under 75N95019D00026, an indefinite delivery contract.
Was contract 75N95019F00088 competed?
The extent of competition for 75N95019F00088 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award